|
Jan 7
|
Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform
|
|
Jan 7
|
Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook
|
|
Jan 7
|
Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow
|
|
Jan 5
|
How Akoya Biosciences (AKYA) Stock Stands Out in a Strong Industry
|
|
Dec 20
|
Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Oct 11
|
Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023
|
|
Aug 8
|
Q2 2023 Akoya Biosciences Inc Earnings Call
|
|
Aug 7
|
Akoya Biosciences (AKYA) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 7
|
Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
|
|
Aug 7
|
Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies
|
|
Aug 6
|
Private equity firms account for 49% of Akoya Biosciences, Inc.'s (NASDAQ:AKYA) ownership, while institutions account for 29%
|